prenalterol has been researched along with xamoterol in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (66.67) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erhardt, PW | 1 |
| Barlow, JJ; Main, BG; Snow, HM | 1 |
| Isogaya, M; Kikkawa, H; Kurose, H; Nagao, T; Sugimoto, Y; Tanaka, R; Tanimura, R | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Halliday, SE; Påby, L; Snow, HM; Vigholt-Sørensen, E | 1 |
| McCaffrey, PM; Riddell, JG; Shanks, RG | 2 |
| Apperley, GH; Drew, GM; Gurden, JM | 1 |
| Hadfield, SE; Slee, SJ; Snow, HM | 1 |
| Beer, M; Hacker, S; Poat, J; Stahl, SM | 1 |
| Komajda, M | 1 |
| Carlier, J; el Allaf, D | 1 |
| Barnett, DB; Cook, N; Richardson, A | 1 |
| Detry, JM; Mancia, G; Pouleur, H | 1 |
| Hanratty, CG; Riddell, JG; Silke, B | 1 |
2 review(s) available for prenalterol and xamoterol
| Article | Year |
|---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
Old and new inotropic drugs.
Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiac Glycosides; Cardiotonic Agents; Catecholamines; Glucagon; Hemodynamics; Humans; Imidazoles; Isoproterenol; Myocardial Contraction; Practolol; Prenalterol; Propanolamines; Stimulation, Chemical; Xamoterol | 1984 |
3 trial(s) available for prenalterol and xamoterol
| Article | Year |
|---|---|
Selectivity of xamoterol, prenalterol and salbutamol as assessed by their effects in the presence and absence of ICI 118 551.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Male; Prenalterol; Propanolamines; Xamoterol | 1990 |
The selectivity of xamoterol, prenalterol, and salbutamol as assessed by their effects in the presence and absence of ICI 118,551.
Topics: Adrenergic beta-Antagonists; Adult; Albuterol; Blood Pressure; Double-Blind Method; Heart Rate; Hemodynamics; Humans; Male; Posture; Prenalterol; Propanolamines; Regional Blood Flow; Tremor; Xamoterol | 1988 |
Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Double-Blind Method; Drug Interactions; Heart Rate; Humans; Male; Prenalterol; Sleep; Statistics as Topic; Xamoterol | 1999 |
10 other study(ies) available for prenalterol and xamoterol
| Article | Year |
|---|---|
Beta-adrenoceptor stimulant properties of amidoalkylamino-substituted 1-aryl-2-ethanols and 1-(aryloxy)-2-propanols.
Topics: Adrenergic beta-Agonists; Animals; Dogs; Ethanolamines; Heart Rate; Propanolamines; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1981 |
Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alanine; Albuterol; Amino Acid Substitution; Animals; Binding Sites; Computer Simulation; COS Cells; Ethanolamines; Formoterol Fumarate; Humans; Models, Molecular; Norepinephrine; Procaterol; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Recombinant Fusion Proteins; Xamoterol | 1999 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Comparative effects of beta-adrenoceptor partial agonists on isolated rat atrium.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Benzeneacetamides; Heart Atria; Heart Rate; Myocardial Contraction; Prenalterol; Propanolamines; Rats; Stimulation, Chemical; Xamoterol | 1991 |
A comparison of the properties of prenalterol and corwin at beta 1- and beta 2-adrenoreceptors in vitro.
Topics: Adrenergic beta-Agonists; Animals; Cats; Dogs; Guinea Pigs; In Vitro Techniques; Isoproterenol; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Prenalterol; Propanolamines; Receptors, Adrenergic, beta; Xamoterol | 1989 |
The cardiovascular pharmacology of xamoterol, cicloprolol, prenalterol and pindolol in the anaesthetised dog.
Topics: Adrenergic beta-Agonists; Anesthesia; Animals; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Hindlimb; Isoproterenol; Pindolol; Prenalterol; Propanolamines; Regional Blood Flow; Reserpine; Xamoterol | 1989 |
Independent regulation of beta 1- and beta 2-adrenoceptors.
Topics: Adrenergic beta-Agonists; Animals; Cerebral Cortex; Clenbuterol; Desipramine; In Vitro Techniques; Iodine Radioisotopes; Male; Pindolol; Prenalterol; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Xamoterol | 1987 |
[New cardiotonic agents].
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Colforsin; Deoxyepinephrine; Humans; Imidazoles; Levodopa; Milrinone; Practolol; Prenalterol; Propanolamines; Pyridones; Quinazolines; Xamoterol | 1985 |
Comparison of the beta 1 selective affinity of prenalterol and corwin demonstrated by radioligand binding.
Topics: Adrenergic beta-Agonists; Animals; Cell Membrane; Dihydroalprenolol; Dose-Response Relationship, Drug; Lung; Male; Practolol; Prenalterol; Propanolamines; Rabbits; Radioligand Assay; Rats; Rats, Inbred Strains; Xamoterol | 1984 |
Inotropic drugs of the future.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Heart Failure; Humans; Imidazoles; Practolol; Prenalterol; Propanolamines; Xamoterol | 1982 |